Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
PRIMAGE project: predictive in silico multiscale analytics to support childhood cancer personalised evaluation empowered by imaging biomarkers.
Martí-Bonmatí L, Alberich-Bayarri Á, Ladenstein R, Blanquer I, Segrelles JD, Cerdá-Alberich L, Gkontra P, Hero B, García-Aznar JM, Keim D, Jentner W, Seymour K, Jiménez-Pastor A, González-Valverde I, Martínez de Las Heras B, Essiaf S, Walker D, Rochette M, Bubak M, Mestres J, Viceconti M, Martí-Besa G, Cañete A, Richmond P, Wertheim KY, Gubala T, Kasztelnik M, Meizner J, Nowakowski P, Gilpérez S, Suárez A, Aznar M, Restante G, Neri E. Martí-Bonmatí L, et al. Among authors: restante g. Eur Radiol Exp. 2020 Apr 3;4(1):22. doi: 10.1186/s41747-020-00150-9. Eur Radiol Exp. 2020. PMID: 32246291 Free PMC article.
Bridging gaps between images and data: a systematic update on imaging biobanks.
Gabelloni M, Faggioni L, Borgheresi R, Restante G, Shortrede J, Tumminello L, Scapicchio C, Coppola F, Cioni D, Gómez-Rico I, Martí-Bonmatí L, Neri E. Gabelloni M, et al. Among authors: restante g. Eur Radiol. 2022 May;32(5):3173-3186. doi: 10.1007/s00330-021-08431-6. Epub 2022 Jan 10. Eur Radiol. 2022. PMID: 35001159 Review.
Pharmacogenetics of androgen signaling in prostate cancer: Focus on castration resistance and predictive biomarkers of response to treatment.
Del Re M, Crucitta S, Restante G, Rofi E, Arrigoni E, Biasco E, Sbrana A, Coppi E, Galli L, Bracarda S, Santini D, Danesi R. Del Re M, et al. Among authors: restante g. Crit Rev Oncol Hematol. 2018 May;125:51-59. doi: 10.1016/j.critrevonc.2018.03.002. Epub 2018 Mar 6. Crit Rev Oncol Hematol. 2018. PMID: 29650277 Review.
Implications of KRAS mutations in acquired resistance to treatment in NSCLC.
Del Re M, Rofi E, Restante G, Crucitta S, Arrigoni E, Fogli S, Di Maio M, Petrini I, Danesi R. Del Re M, et al. Among authors: restante g. Oncotarget. 2017 Dec 21;9(5):6630-6643. doi: 10.18632/oncotarget.23553. eCollection 2018 Jan 19. Oncotarget. 2017. PMID: 29464099 Free PMC article. Review.
Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring.
Pasqualetti F, Restante G, Gonnelli A, Rofi E, Molinari A, Crucitta S, Paiar F, Rudà R, Danesi R, Soffietti R, Del Re M. Pasqualetti F, et al. Among authors: restante g. Neuro Oncol. 2019 Dec 17;21(12):1610-1611. doi: 10.1093/neuonc/noz157. Neuro Oncol. 2019. PMID: 31504796 Free PMC article. No abstract available.
Clinical pharmacology of monoclonal antibodies targeting PD-1 axis in urothelial cancers.
Rofi E, Del Re M, Arrigoni E, Rizzo M, Fontanelli L, Crucitta S, Gianfilippo G, Restante G, Fogli S, Porta C, Danesi R, Schmidinger M. Rofi E, et al. Among authors: restante g. Crit Rev Oncol Hematol. 2020 Oct;154:102891. doi: 10.1016/j.critrevonc.2020.102891. Epub 2020 Apr 25. Crit Rev Oncol Hematol. 2020. PMID: 32340783 Free article.
Androgen receptor gain in circulating free DNA and splicing variant 7 in exosomes predict clinical outcome in CRPC patients treated with abiraterone and enzalutamide.
Del Re M, Conteduca V, Crucitta S, Gurioli G, Casadei C, Restante G, Schepisi G, Lolli C, Cucchiara F, Danesi R, De Giorgi U. Del Re M, et al. Among authors: restante g. Prostate Cancer Prostatic Dis. 2021 Jun;24(2):524-531. doi: 10.1038/s41391-020-00309-w. Epub 2021 Jan 26. Prostate Cancer Prostatic Dis. 2021. PMID: 33500577 Free PMC article.
22 results